Anthem Biosciences Peer Comparison

NSE: ANTHEM | BSE: 544449

₹822.15

₹-19.95 (-2.37%)

As on 16-Oct-2026IST

Market cap

₹46,567 Cr

Revenue (TTM)

₹2,002 Cr

P/E Ratio

80.9

P/B Ratio

14.9

Div. Yield

0.2 %

Edit

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Market cap (₹ Cr)	46,567	2,344	178	168	82,444
Revenue (₹ Cr)	2,002	419	71	--	8,712
Net Profit (₹ Cr)	575.95	79.66	5.14	-0.86	1,457.40
Net Margin (%)	26.66	18.53	7.16	-2,391.67	16.41
RoE (%)	20.48	18.52	5.85	-3.56	14.39
Price to Earnings	80.85	29.43	51.02	--	56.59
Price-To-Book	14.88	4.98	2.44	4.22	7.54

Income Statement (₹ Cr)

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Operating Revenue	2,124.33	407.29	46.84	--	8,373.45
Total Income	2,280.12	416.28	47.52	3.67	8,538.02
Total Expenditure	1,290.36	265.77	39.30	0.16	6,132.57
EBITDA	833.97	141.52	7.55	-0.16	2,240.88
Depreciation	134.07	43.77	6.25	--	446.53
EBIT	699.90	97.75	1.29	-0.16	1,794.35
Interest	7.06	1.17	1.92	--	235.10
Other Income	155.78	8.99	0.68	3.67	164.57
Exceptional Items	-24.39	-1.62	--	--	-48.24
Profit before Tax	824.24	103.95	0.05	3.50	1,675.58
Provision for Tax	232.45	26.44	-0.01	--	233.17
Profit after Tax	591.79	77.51	0.06	3.50	1,442.41

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Shareholder's Funds	3,042.52	456.87	49.94	8.53	10,746.63
Minority Interest	--	--	0.13	--	--
Non-Current Liabilities	33.74	33.55	15.23	--	4,250.88
Current Liabilities	529.71	65.52	12.07	0.30	2,186.94
Total Liabilities	3,633.29	562.23	78.29	8.84	17,184.45

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Non-Current Assets	1,598.82	331.07	48.61	--	15,239.66
Current Assets	2,007.15	224.87	28.76	8.84	1,944.79
Total Assets	3,633.29	562.23	78.29	8.84	17,184.45
Total Debt*	51.07	3.33	15.14	0.00	2,906.82
Net Current Assets	1,477.43	159.35	16.69	8.53	-242.15
Contingent Liabilities	90.20	1.95	--	--	934.37

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Cash From Operating Activities	844.49	147.14	10.07	0.00	1,633.32
Cash Flow from Investing Activities	-701.62	-129.67	-15.62	--	-1,688.99
Cash from Financing Activities	-40.00	-10.35	5.24	--	59.27
Net Cash Inflow / Outflow	102.87	7.12	-0.30	0.00	3.60

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
ROCE (%)	29.62	24.81	3.17	51.69	14.97
ROE (%)	21.98	18.87	0.14	51.69	14.53
ROA (%)	18.06	15.25	0.08	49.91	8.91
EBIT Margin (%)	46.59	36.95	17.55	--	28.73
Net Margin (%)	25.95	18.62	0.12	95.57	16.89
Cash Profit Margin (%)	33.25	29.78	13.47	--	22.56

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Revenue Growth (%)	15.17	18.40	18.14	--	19.14
EBIT Growth (%)	30.79	19.27	53.88	192.30	20.01
Net Profit Growth (%)	31.14	16.11	104.45	192.29	34.07
EPS Growth (%)	30.53	15.59	109.10	192.29	33.93
Book Value Growth (%)	26.67	20.79	1.09	69.71	14.45

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Price / Earnings	62.29	21.95	526.25	6.80	64.88
Price / Book Value	12.25	3.78	1.45	2.79	8.83
Dividend Yield (%)	0.30	0.53	0.00	0.00	0.21
EV/EBITDA	37.02	10.89	9.54	6.80	39.82
Market Cap (₹ Cr)	36,865.25	1,701.05	63.50	--	93,580.84

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Debt to Equity	0.02	0.01	0.34	0.00	0.27
Short term debt to equity ratio	0.00	--	0.02	--	0.01
Current Ratio	3.79	3.43	2.38	29.18	0.89
Quick Ratio	3.55	2.97	2.25	29.18	0.84
Interest Coverage	117.83	90.08	1.03	--	8.13

	Anthem Biosciences	Vimta Labs	Jeevan Scientific	Genesis IBRC India	Max Healthcare
Debtors to sales (%)	27.80	25.95	34.03	--	11.58
Asset Turnover	0.67	0.80	0.65	0.00	0.52
Receivable days	87.02	94.97	110.00	--	36.12
Inventory Days	38.87	24.65	10.55	--	4.81
Payable days	41.63	--	255.53	--	169.18
Cash Conversion Cycle	84.26	--	-134.98	--	-128.26

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.